 |
|
|
| |
Re-suppression regimens and outcomes after virological failure in randomised controlled trials and real-world evidence studies evaluating cabotegravir and rilpivirine (LAI CAB+RPV)
|
| |
| |
HIV Glasgow 2024 (November 10-13), Scotland
Ms Alexa Elias1, Dr Melanie Smuk1, Dr Kyle Ring1 2, Prof Chloe Orkin1 2
1 SHARE Collaborative, Blizard Institute, Queen Mary University of London,, London, UK, 2Barts Health NHS Trust, London, UK
|
| |
|
|
|
|
|
